53425-61-9

Upstream product

• 91-62-3 6-methylquinoline 
• 151-50-8 potassium cyanide 
• 98-88-4 benzoyl chloride 

Downstream Products

• 141813-00-5 1-Benzoyl-3-bromo-4-methoxy-6-methyl-1,2,3,4-tetrahydro-quinoline-2-carbonitrile 
• 99842-59-8 4-Methoxy-6-methyl-chinolin 
• 511234-63-2 1-Benzoyl-2-cyano-5-fluoro-1,2-dihydroquinoline 
• 1276669-33-0 C₂₁H₂₀N₂O 
• 511231-69-9 1-Benzoyl-5-chloro-2-cyano-1,2-dihydroquinoline 
• 15733-84-3 6-methyl-quinoline-2-carboxylic acid 

Relevant academic research and scientific papers

Novel N-acylated heterocycles

Described are compositions comprising a muscarinic receptor antagonist and an N-acylated heterocycle derivative having affinity for serotonergic receptors, and enantiomers, diastereoisomers, N-oxides, polymorphs, solvates and pharmaceutically acceptable salts thereof. The combination of a muscarinic receptor antagonist and an N-acylated heterocycle, or an enantiomer, diastereoisomer, N-oxide, polymorph, solvate or pharmaceutically acceptable salt thereof, is useful in the treatment of patients with neuromuscular dysfunction of the lower urinary tract and diseases related to 5-HT1A receptors.

1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids

A series of 1-[acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids and salts thereof are useful as Angiotensin I converting enzyme inhibitors.